Your browser doesn't support javascript.
loading
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.
Cortellini, Alessio; Tiseo, Marcello; Banna, Giuseppe L; Cappuzzo, Federico; Aerts, Joachim G J V; Barbieri, Fausto; Giusti, Raffaele; Bria, Emilio; Cortinovis, Diego; Grossi, Francesco; Migliorino, Maria R; Galetta, Domenico; Passiglia, Francesco; Santini, Daniele; Berardi, Rossana; Morabito, Alessandro; Genova, Carlo; Mazzoni, Francesca; Di Noia, Vincenzo; Signorelli, Diego; Tuzi, Alessandro; Gelibter, Alain; Marchetti, Paolo; Macerelli, Marianna; Rastelli, Francesca; Chiari, Rita; Rocco, Danilo; Gori, Stefania; De Tursi, Michele; Mansueto, Giovanni; Zoratto, Federica; Santoni, Matteo; Tudini, Marianna; Rijavec, Erika; Filetti, Marco; Catino, Annamaria; Pizzutilo, Pamela; Sala, Luca; Citarella, Fabrizio; Marco, Russano; Torniai, Mariangela; Cantini, Luca; Targato, Giada; Sforza, Vincenzo; Nigro, Olga; Ferrara, Miriam G; D'Argento, Ettore; Buti, Sebastiano; Bordi, Paola; Antonuzzo, Lorenzo.
Afiliação
  • Cortellini A; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy. alessiocortellini@gmail.com.
  • Tiseo M; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, 67100, L'Aquila, Italy. alessiocortellini@gmail.com.
  • Banna GL; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Cappuzzo F; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Aerts JGJV; Oncology Department, United Lincolnshire Hospital NHS Trust, Lincoln, UK.
  • Barbieri F; Department of Oncology and Hematology, AUSL Romagna, Ravenna, Italy.
  • Giusti R; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Bria E; Department of Oncology and Hematology, Modena University Hospital, Modena, Italy.
  • Cortinovis D; Medical Oncology Unit, Sant' Andrea Hospital fo Rome, Rome, Italy.
  • Grossi F; Comprehensive Cancer Center, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
  • Migliorino MR; Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Galetta D; Medical Oncology, Ospedale San Gerardo, Monza, Italy.
  • Passiglia F; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Santini D; Pneumo-Oncology Unit, St. Camillo-Forlanini Hospital, Rome, Italy.
  • Berardi R; Thoracic Oncology Unit, Clinical Cancer Center, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Morabito A; Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, TO, Italy.
  • Genova C; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Mazzoni F; Oncology Clinic, Ospedali Riuniti Di Ancona, Università Politecnica Delle Marche, Ancona, Italy.
  • Di Noia V; Thoracic Medical Oncology, Istituto Nazionale Tumori 'Fondazione G Pascale', IRCCS, Naples, Italy.
  • Signorelli D; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Tuzi A; Department of Oncology, Careggi University Hospital, Florence, Italy.
  • Gelibter A; Medical Oncology, University Hospital of Foggia, Foggia, Italy.
  • Marchetti P; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Macerelli M; Medical Oncology, ASST-Sette Laghi, Varese, Italy.
  • Rastelli F; Medical Oncology (B), Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Chiari R; Medical Oncology Unit, Sant' Andrea Hospital fo Rome, Rome, Italy.
  • Rocco D; Medical Oncology (B), Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Gori S; Department of Clinical and Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.
  • De Tursi M; Department of Oncology, University Hospital Santa Maria Della Misericordia, Udine, Italy.
  • Mansueto G; Medical Oncology, Fermo Area Vasta 4, Fermo, Italy.
  • Zoratto F; Medical Oncology, Ospedali Riuniti Padova Sud "Madre Teresa Di Calcutta", Monselice, Italy.
  • Santoni M; Pneumo-Oncology Unit, Monaldi Hospital, Naples, Italy.
  • Tudini M; Oncology Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, VR, Italy.
  • Rijavec E; Department of Medical, Oral and Biotechnological Sciences, University G. D'Annunzio, Chieti-Pescara, Chieti, Italy.
  • Filetti M; Medical Oncology, F. Spaziani Hospital, Frosinone, Italy.
  • Catino A; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy.
  • Pizzutilo P; Department of Oncology, Macerata Hospital, Macerata, Italy.
  • Sala L; Medical Oncology, AV2 Fabriano ASUR Marche, Fabriano, Italy.
  • Citarella F; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Marco R; Medical Oncology Unit, Sant' Andrea Hospital fo Rome, Rome, Italy.
  • Torniai M; Thoracic Oncology Unit, Clinical Cancer Center, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Cantini L; Thoracic Oncology Unit, Clinical Cancer Center, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Targato G; Medical Oncology, Ospedale San Gerardo, Monza, Italy.
  • Sforza V; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Nigro O; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Ferrara MG; Oncology Clinic, Ospedali Riuniti Di Ancona, Università Politecnica Delle Marche, Ancona, Italy.
  • D'Argento E; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Buti S; Oncology Clinic, Ospedali Riuniti Di Ancona, Università Politecnica Delle Marche, Ancona, Italy.
  • Bordi P; Department of Oncology, University Hospital Santa Maria Della Misericordia, Udine, Italy.
  • Antonuzzo L; Thoracic Medical Oncology, Istituto Nazionale Tumori 'Fondazione G Pascale', IRCCS, Naples, Italy.
Cancer Immunol Immunother ; 69(11): 2209-2221, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32474768
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália País de publicação: Alemanha